You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 147 No. 4, April 1987 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL INVESTIGATIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Treatment of Postmenopausal Hyperparathyroidism With Norethindrone

Effects on Biochemistry and Forearm Mineral Density

Michael Horowitz, PhD, FRACP; Judith Wishart; Allan G. Need, FRACP; Howard Morris, PhD; Jeffrey Philcox, FAIMLS; B. E. Christopher Nordin, DSc, FRACP

Arch Intern Med. 1987;147(4):681-685.


Abstract

• The effects of norethindrone (5 mg daily) on biochemical variables and forearm mineral density were assessed in 20 postmenopausal women with mild primary hyperparathyroidism. Norethindrone produced a significant fall in plasma calcium levels and the fasting urinary calcium-creatinine and hydroxyproline-creatinine ratios after three months of treatment. There was no change in the plasma parathyroid hormone concentrations. The forearm mineral density before treatment was low in 16 of the 20 patients and there was a significant increase in forearm mineral density after norethindrone treatment. No side effects were reported. We conclude that norethindrone is an effective treatment for mild hyperparathyroidism in postmenopausal women.

(Arch Intern Med 1987;147:681-685)



Author Affiliations

From the Department of Medicine, University of Adelaide (Dr Horowitz and Ms Wishart), Endocrine Unit, Royal Adelaide Hospital (Dr Nordin), and the Institute of Medical and Veterinary Science (Drs Need, Morris, and Philcox), Adelaide, South Australia.


Footnotes

Accepted for publication July 21, 1986.

Reprint requests to Department of Medicine, Royal Adelaide Hospital, North Terrace, Adelaide, South Australia 5000 (Dr Horowitz).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Treatment of Postmenopausal Hyperparathyroidism With Norethindrone: Long-term Effects on Forearm Mineral Content
Wishart et al.
Arch Intern Med 1990;150:1951-1953.
ABSTRACT  

Relationship Between Forearm and Vertebral Mineral Density in Postmenopausal Women With Primary Hyperparathyroidism
Wishart et al.
Arch Intern Med 1990;150:1329-1331.
ABSTRACT  

Primary Hyperparathyroidism: A Review of the Long-term Surgical and Nonsurgical Morbidities as a Basis for a Rational Approach to Treatment
Lafferty and Hubay
Arch Intern Med 1989;149:789-796.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1987 American Medical Association. All Rights Reserved.